Wedbush Has Positive Estimate for Chimerix FY2028 Earnings
Chimerix, Inc. (NASDAQ:CMRX – Free Report) – Equities research analysts at Wedbush boosted their FY2028 earnings per share estimates for shares of Chimerix in a research note issued on Tuesday, February 18th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will earn $0.58 per share for the year, up from their previous forecast […]
Chimerix, Inc. (NASDAQ:CMRX – Free Report) – Equities research analysts at Wedbush boosted their FY2028 earnings per share estimates for shares of Chimerix in a research note issued on Tuesday, February 18th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will earn $0.58 per share for the year, up from their previous forecast […]
